基于“心与小肠相表里”理论,探讨肠道菌群与冠心病合并焦虑抑郁状态的关系
Exploring the Relationship between Intestinal Flora and Depression in Coronary Heart Disease Based on the Theory of “Heart and Small Intestine Being Paired Organs”
DOI: 10.12677/acm.2026.161181, PDF,   
作者: 孙 璐:黑龙江中医药大学第一临床医学院,黑龙江 哈尔滨;金 娟*:黑龙江中医药大学附属第一医院心血管病一科,黑龙江 哈尔滨
关键词: “心与小肠相表里”肠道菌群冠心病焦虑抑郁状态“Heart and Small Intestine Being Paired Organs” Intestinal Flora Coronary Heart Disease Depression
摘要: “心与小肠相表里”是中医理论中阐述心与小肠通过经络相互络属、气血相通、功能协同的重要理论。现代研究表明,肠道菌群作为“小肠”功能的微观体现,与冠心病及其常伴发的焦虑抑郁状态之间存在密切关联。本文基于“心与小肠相表里”理论,系统梳理心与小肠在生理、病理上的相互关系,并结合肠道微生态研究进展,深入探讨肠道菌群失调通过菌群–肠–脑轴、免疫炎症通路、代谢产物等具体途径在冠心病与焦虑抑郁共病机制中的核心作用。进一步提出,清热化痰、疏肝理气、活血化瘀等类中药及其活性成分可通过多靶点调节肠道菌群结构、改善菌群代谢功能、修复肠屏障、调节免疫与神经递质,从而干预冠心病合并焦虑抑郁的病理进程,为“双心同治”提供中西医结合的理论依据与精准治疗新策略。
Abstract: The concept of “heart and small intestine being paired organs” is a fundamental theory in traditional Chinese medicine, describing how the heart and small intestine are interconnected through meridians, share mutual circulation of qi and blood, and function synergistically. Modern research indicates that the gut microbiota, as a microscopic manifestation of small intestinal function, is closely associated with coronary heart disease and its frequently accompanying anxiety and depression. Based on this theory, this paper systematically reviews the physiological and pathological interrelationships between the heart and small intestine. Integrating advances in gut microbiome research, it explores how dysbiosis mediates the co-morbidity of CHD and anxiety-depression through specific pathways: the microbiota-gut-brain axis, immune-inflammatory pathways, and metabolic products. Furthermore, it proposes that traditional Chinese medicine (TCM) formulations and their active components—such as those that clear heat and resolve phlegm, soothe the liver and regulate qi, and activate blood and resolve stasis—can intervene in the pathological progression of CHD with anxiety and depression. This is achieved through multi-target regulation of gut microbiota structure, improvement of microbial metabolic function, restoration of the intestinal barrier, and modulation of immunity and neurotransmitters. This approach provides a theoretical basis and precision treatment strategy for “dual-heart co-treatment” integrating Chinese and Western medicine.
文章引用:孙璐, 金娟. 基于“心与小肠相表里”理论,探讨肠道菌群与冠心病合并焦虑抑郁状态的关系[J]. 临床医学进展, 2026, 16(1): 1406-1413. https://doi.org/10.12677/acm.2026.161181

参考文献

[1] Chauvet-Gélinier, J., Trojak, B., Vergès-Patois, B., Cottin, Y. and Bonin, B. (2013) Review on Depression and Coronary Heart Disease. Archives of Cardiovascular Diseases, 106, 103-110. [Google Scholar] [CrossRef] [PubMed]
[2] Wu, Y., Zhu, B., Chen, Z., Duan, J., Luo, A., Yang, L., et al. (2021) New Insights into the Comorbidity of Coronary Heart Disease and Depression. Current Problems in Cardiology, 46, Article 100413. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, H., Jing, L., Zhai, C., Xiang, Q., Tian, H. and Hu, H. (2022) Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease. Journal of Cardiovascular Pharmacology, 81, 175-182. [Google Scholar] [CrossRef] [PubMed]
[4] 王俊雄, 杨莺. 基于“心合小肠”理论辨治冠心病[J]. 实用中医内科杂志, 2025, 39(1): 136-138.
[5] 钱煜雯, 罗立波, 廉源沛, 申春悌, 颜晓静, 刘潘. 冠心病合并焦虑抑郁状态发病机制及其中西医治疗研究进展[J]. 中国现代医药杂志, 2024, 26(8): 80-87.
[6] 何彦虎, 金华, 刘志军, 司美龙, 胡芝霞, 张俊鹏, 刘双芳, 凌必时, 朱飞飞. 基于“心合小肠”理论探讨肠道菌群是冠心病干预的新靶点[J]. 中国微生态学杂志, 2022, 34(12): 1461-1466.
[7] 周佳佳, 阳正国, 李美其. 中药调节肠道菌群治疗肠易激综合征研究进展[J]. 实用中医药杂志, 2024, 40(7): 1447-1450.
[8] Jin, M., Qian, Z., Yin, J., Xu, W. and Zhou, X. (2019) The Role of Intestinal Microbiota in Cardiovascular Disease. Journal of Cellular and Molecular Medicine, 23, 2343-2350. [Google Scholar] [CrossRef] [PubMed]
[9] 朱文, 谢凤群, 程洁, 冯其茂. 基于“心与小肠相表里”理论探讨肠道菌群与高血压的关系[J]. 上海中医药杂志, 2023, 57(8): 57-62.
[10] Vaiserman, A., Romanenko, M., Piven, L., Moseiko, V., Lushchak, O., Kryzhanovska, N., et al. (2020) Differences in the Gut Firmicutes to Bacteroidetes Ratio across Age Groups in Healthy Ukrainian Population. BMC Microbiology, 20, Article No. 221. [Google Scholar] [CrossRef] [PubMed]
[11] Zhi, C., Huang, J., Wang, J., Cao, H., Bai, Y., Guo, J., et al. (2019) Connection between Gut Microbiome and the Development of Obesity. European Journal of Clinical Microbiology & Infectious Diseases, 38, 1987-1998. [Google Scholar] [CrossRef] [PubMed]
[12] Anhê, F.F., Barra, N.G., Cavallari, J.F., Henriksbo, B.D. and Schertzer, J.D. (2021) Metabolic Endotoxemia Is Dictated by the Type of Lipo-Polysaccharide. Cell Reports, 36, Article 109691.
[13] Jie, Z., Xia, H., Zhong, S., Feng, Q., Li, S., Liang, S., et al. (2017) The Gut Microbiome in Atherosclerotic Cardiovascular Disease. Nature Communications, 8, Article No. 845. [Google Scholar] [CrossRef] [PubMed]
[14] Lanter, B.B., Sauer, K. and Davies, D.G. (2014) Bacteria Present in Carotid Arterial Plaques Are Found as Biofilm Deposits Which May Contribute to Enhanced Risk of Plaque Rupture. mBio, 5, e01206‐e01214. [Google Scholar] [CrossRef] [PubMed]
[15] Sanchez-Gimenez, R., Ahmed-Khodja, W., Molina, Y., Peiró, O.M., Bonet, G., Carrasquer, A., et al. (2022) Gut Microbiota-Derived Metabolites and Cardiovascular Disease Risk: A Systematic Review of Prospective Cohort Studies. Nutrients, 14, Article 2654. [Google Scholar] [CrossRef] [PubMed]
[16] Hoyles, L., Jiménez-Pranteda, M.L., Chilloux, J., Brial, F., Myridakis, A., Aranias, T., et al. (2018) Metabolic Retroconversion of Trimethylamine N-Oxide and the Gut Microbiota. Microbiome, 6, 1-14. [Google Scholar] [CrossRef] [PubMed]
[17] Neinast, M., Murashige, D. and Arany, Z. (2019) Branched Chain Amino Acids. Annual Review of Physiology, 81, 139-164. [Google Scholar] [CrossRef] [PubMed]
[18] Fine, K.S., Wilkins, J.T. and Sawicki, K.T. (2024) Circulating Branched Chain Amino Acids and Cardiometabolic Disease. Journal of the American Heart Association, 13, e031617. [Google Scholar] [CrossRef] [PubMed]
[19] Ott, S.J., El Mokhtari, N.E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., et al. (2006) Detection of Diverse Bacterial Signatures in Atherosclerotic Lesions of Patients with Coronary Heart Disease. Circulation, 113, 929-937. [Google Scholar] [CrossRef] [PubMed]
[20] Karbach, S.H., Schönfelder, T., Brandão, I., Wilms, E., Hörmann, N., Jäckel, S., et al. (2016) Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction. Journal of the American Heart Association, 5, 1-12. [Google Scholar] [CrossRef] [PubMed]
[21] Sanz, Y. and Moya-Pérez, A. (2014) Microbiota, Inflammation and Obesity. In: Lyte, M. and Cryan, J., Eds., Advances in Experimental Medicine and Biology, Springer, 291-317. [Google Scholar] [CrossRef] [PubMed]
[22] Dinan, T.G. and Cryan, J.F. (2016) Gut Instincts: Microbiota as a Key Regulator of Brain Development, Ageing and Neurodegeneration. The Journal of Physiology, 595, 489-503. [Google Scholar] [CrossRef] [PubMed]
[23] Sherwin, E., Sandhu, K.V., Dinan, T.G. and Cryan, J.F. (2016) May the Force Be with You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry. CNS Drugs, 30, 1019-1041. [Google Scholar] [CrossRef] [PubMed]
[24] Hamon, M. and Blier, P. (2013) Monoamine Neurocircuitry in Depression and Strategies for New Treatments. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 45, 54-63. [Google Scholar] [CrossRef] [PubMed]
[25] Schildkraut, J.J. (1965) The Catecholamine Hypothesis of Affective Disorders: A Review of Supporting Evidence. American Journal of Psychiatry, 122, 509-522. [Google Scholar] [CrossRef] [PubMed]
[26] Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., et al. (2015) Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis. Cell, 161, 264-276. [Google Scholar] [CrossRef] [PubMed]
[27] Park, H.‐J., Lee, S.‐E., Kim, H.‐B., Isaacson, R.E., Seo, K.‐W. and Song, K.‐H. (2014) Association of Obesity with Serum Leptin, Adiponectin, and Serotonin and Gut Microflora in Beagle Dogs. Journal of Veterinary Internal Medicine, 29, 43-50. [Google Scholar] [CrossRef] [PubMed]
[28] sin, K., Batirel, S., Ülfer, G., Yigit, P. and Sanlier, N. (2023) Association of Serum Irisin Levels with Body Composition, Metabolic Profile, Leptin, and Adiponectin Levels in Lean and Obese Children. Medicina, 59, Article 1954. [Google Scholar] [CrossRef] [PubMed]
[29] Möhle, L., Mattei, D., Heimesaat, M.M., Bereswill, S., Fischer, A., Alutis, M., et al. (2016) Ly6chi Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis. Cell Reports, 15, 1945-1956. [Google Scholar] [CrossRef] [PubMed]
[30] Fröhlich, E.E., Farzi, A., Mayerhofer, R., Reichmann, F., Jačan, A., Wagner, B., et al. (2016) Cognitive Impairment by Antibiotic-Induced Gut Dysbiosis: Analysis of Gut Microbiota-Brain Communication. Brain, Behavior, and Immunity, 56, 140-155. [Google Scholar] [CrossRef] [PubMed]
[31] van Heesch, F. (2014) Studying the Role of Proinflammatory Cytokines in Anhedonia. Utrecht University.
[32] 周芙琼, 左可可, 顾宁. 基于“心与小肠相表里”探讨心肌缺血再灌注损伤的防治策略[J]. 中西医结合心脑血管病杂志, 2023, 21(3): 555-558.
[33] 杨珂鸣, 贾越博, 叶丽亚·叶尔太, 等. 柴胡疏肝散对功能性消化不良模型大鼠十二指肠黏膜屏障和肠道菌群的影响[J]. 中医杂志, 2023, 64(23): 2443-2453.
[34] Headrick, J.P., Peart, J.N., Budiono, B.P., Shum, D.H.K., Neumann, D.L. and Stapelberg, N.J.C. (2017) The Heartbreak of Depression: ‘Psycho-Cardiac’ Coupling in Myocardial Infarction. Journal of Molecular and Cellular Cardiology, 106, 14-28. [Google Scholar] [CrossRef] [PubMed]
[35] 李亚欢, 梁星辰, 姜会梨, 等. SP600125阻断JNK信号通路下电针对慢性不可预知性温和应激大鼠HPA轴的影响[J]. 针灸临床杂志, 2019, 35(9): 62-7, 101.
[36] 徐珊珊, 阎玲, 张乃卫, 等. 加味温胆汤对反流性食管炎患者胃肠动力及肠道菌群影响[J]. 辽宁中医药大学学报, 2023, 25(7): 125-128.
[37] 杨小英, 陈春玲, 马晓聪, 等. 基于网络药理学探讨温胆汤治疗高血压的作用机制[J]. 中西医结合心脑血管病杂志, 2020, 18(24): 4108-4116.
[38] 吴俊颖, 张璐, 谢铱子, 等. 基于网络药理学研究温胆汤治疗冠心病的作用机制[J]. 中国药房, 2018, 29(23): 3227-3232.
[39] 吴卓耘. 基于GABA能系统探讨温胆汤对创伤后应激障碍相关神经心理异常调节机制[D]: [硕士学位论文]. 北京: 北京中医药大学, 2016.
[40] 王亚楠, 孙宏, 王秀珍, 梁国英, 蔡国锋, 刘凯, 裴思颖, 张金朋. 基于肠道菌-神经递质-脑轴探讨柴胡加龙骨牡蛎汤对大鼠焦虑抑郁状态的改善作用[J]. 中成药, 2023, 45(10): 3446-3452.
[41] 马迪. 冠心病合并焦虑心胆郁热证的炎性特征及柴胡加龙骨牡蛎汤的机制研究[D]: [博士学位论文]. 北京: 北京中医药大学, 2023.
[42] 孙广瀚, 谢珍聪, 孙咪, 等. 瓜蒌-薤白调节肠道菌群治疗冠心病模型大鼠的作用及机制[J]. 中国组织工程研究, 2025, 29(5): 917-927.
[43] 吴山永, 褚振亮, 赵圣刚, 等. 加味半夏泻心汤治疗冠心病临床疗效及对其肠道菌群的影响[J]. 浙江中医杂志, 2024, 59(7): 607-608.
[44] 董嘉琪, 马丽娜, 张博庸. 中药调节肠道菌群治疗心血管疾病的研究进展[J]. 现代医学与健康研究电子杂志, 2024, 8(14): 131-134.